An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for <i>Chlamydia trachomatis</i> and <i>Neisseria gonorrhoea</i> in genitourinary medicine clinics in England

Abstract

Replacing standard laboratory tests for chlamydia and gonorrhoea with a POC test could be cost saving and patients would benefit from more accurate diagnosis and less unnecessary treatment. Overtreatment currently accounts for about a tenth of the reported treatments for chlamydia and gonorrhoea and POC NAATs would effectively eliminate the need for presumptive treatment.